 NW, Ste G253, Washington,
DC 20010 (e-mail: john.j.ricotta@medstar.net).
The editors and reviewers of this article have no relevant financial relationships
to disclose per the JVS policy that requires reviewers to decline review of any
manuscript for which they may have a competition of interest.
0741-5214/$36.00
Copyright © 2011 by the Society for Vascular Surgery.
doi:10.1016/j.jvs.2011.07.031

A. Carotid duplex ultrasound imaging
B. Magnetic resonance imaging and angiography
C. Computed tomography angiography
D. Catheter-based digital subtraction arteriography
E. Comparison of CDUS, MRA, CTA, and DSA
● Recommendations for selection of carotid imaging modalities
III. Medical management of patients with carotid stenosis
A. Treatment of hypertension
B. Treatment of diabetes mellitus
C. Treatment of lipid abnormalities
D. Smoking cessation
E. Antithrombotic treatment
F. Anticoagulant therapy
G. Medical management for the perioperative period
of CEA
H. Medical management for the perioperative period
of CAS
● Recommendations for medical management of
patients with carotid atherosclerosis
IV. Technical recommendations for carotid interventions
A. Carotid endarterectomy
B. Carotid artery stenting
● Recommendations regarding CEA and CAS technique
V. Selecting the appropriate therapy: medical management, CAS, or CEA
e1

e2 Ricotta et al

A. Assessing the risk associated with intervention
1. Anatomic and lesion characteristics
a. Lesion location
b. Lesion characteristics
c. Other anatomic considerations
2. Patient characteristics
B. Neurologically asymptomatic patients with ⱖ60%
carotid artery stenosis
1. CEA for asymptomatic lesions
2. CAS in asymptomatic lesions
3. Medical management of asymptomatic carotid
stenosis
C. Neurologically symptomatic patients with ⱖ50%
carotid artery disease
1. CEA in symptomatic stenosis
2. CAS in symptomatic stenosis
D